An implementation science approach to determine the barriers and facilitators to hepatitis C virus testing in English remand prisons: a mixed-methods study
The rates of testing for HCV in three category B male remand prisons were far below national standards. Key recommendations to improve testing rates, based on the CFIR analysis are (1) to appoint a dedicated senior healthcare staff member who combines responsibility, accountability and authority to proactively oversee testing and ongoing referral processes; (2) to reintroduce an education programme for prison healthcare teams to teach about HCV, cirrhosis and how to deliver 'opt-out' conversations and respond to typical responses and (3) to adopt more widely the strategy already shown to be successful in increasing test uptake by the Hepatitis C Trust HITT programme and offer simple incentives.
Authors
- Zoe Rose
- Kathryn Jack (ORCID: https://orcid.org/0000-0002-8596-4073)
- Brian J. Thomson (ORCID: https://orcid.org/0000-0001-8490-2332)
- William L. Irving (ORCID: https://orcid.org/0000-0002-7268-3168)
Institutions
- Nottingham University Hospitals NHS Trust (GB)
- University of Nottingham (GB)
- Nottinghamshire Healthcare NHS Foundation Trust (GB)
Publication Details
- Journal
- BMJ Open
- Published
- 2025-10-01
- DOI
- https://doi.org/10.1136/bmjopen-2024-092965
- Primary Topic
- Hepatitis C virus research
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- Bristol-Myers Squibb
- Pfizer
- GlaxoSmithKline
- Gilead Sciences
- Norgine
- Cilag